Eversept Partners as of Sept. 30, 2020
Portfolio Holdings for Eversept Partners
Eversept Partners holds 48 positions in its portfolio as reported in the September 2020 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Horizon Therapeutics Pub L SHS | 10.6 | $47M | 608k | 77.68 | |
Amarin Corp Spons Adr New (AMRN) | 10.1 | $45M | 11M | 4.21 | |
Tg Therapeutics (TGTX) | 6.2 | $27M | 1.0M | 26.76 | |
Ascendis Pharma A/s Sponsored Adr (ASND) | 5.6 | $25M | 161k | 154.32 | |
United Therapeutics Corporation (UTHR) | 5.5 | $24M | 241k | 101.00 | |
Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 4.9 | $22M | 2.4M | 9.01 | |
Fate Therapeutics (FATE) | 4.8 | $21M | 535k | 39.97 | |
Biohaven Pharmaceutical Holding | 4.7 | $21M | 322k | 65.01 | |
Deciphera Pharmaceuticals | 4.6 | $21M | 402k | 51.30 | |
Ensign (ENSG) | 4.1 | $18M | 319k | 57.11 | |
Heska Corp Com Restrc New | 3.5 | $16M | 159k | 98.79 | |
Zogenix Com New | 3.5 | $16M | 865k | 17.93 | |
Catalent (CTLT) | 2.7 | $12M | 140k | 85.66 | |
OraSure Technologies (OSUR) | 2.6 | $11M | 940k | 12.17 | |
Amneal Pharmaceuticals Com Stk Cl A (AMRX) | 2.3 | $10M | 2.7M | 3.88 | |
D Fluidigm Corp Del (LAB) | 2.2 | $9.7M | 1.3M | 7.43 | |
Qiagen Nv Shs New | 2.0 | $8.8M | 168k | 52.26 | |
Taro Pharmaceutical Inds SHS (TARO) | 1.8 | $7.8M | 142k | 54.85 | |
Danaher Corporation (DHR) | 1.5 | $6.8M | 31k | 215.50 | |
Model N (MODN) | 1.5 | $6.7M | 189k | 35.28 | |
Hca Holdings (HCA) | 1.5 | $6.5M | 52k | 124.68 | |
Aurinia Pharmaceuticals (AUPH) | 1.4 | $6.4M | 436k | 14.73 | |
Momenta Pharmaceuticals | 1.2 | $5.2M | 99k | 52.48 | |
Mylan Nv Shs Euro | 1.1 | $4.8M | 325k | 14.83 | |
Intra Cellular Therapies (ITCI) | 1.0 | $4.5M | 177k | 25.66 | |
Affimed Therapeutics B V | 0.9 | $4.2M | 1.2M | 3.39 | |
BioCryst Pharmaceuticals (BCRX) | 0.9 | $3.9M | 1.1M | 3.44 | |
Oxford Immunotec Global Ord Shs | 0.8 | $3.4M | 293k | 11.70 | |
Astrazeneca Sponsored Adr (AZN) | 0.8 | $3.3M | 61k | 54.80 | |
Mersana Therapeutics (MRSN) | 0.6 | $2.6M | 140k | 18.62 | |
Sanofi Sponsored Adr (SNY) | 0.6 | $2.5M | 50k | 50.16 | |
Glaxosmithkline Sponsored Adr | 0.6 | $2.5M | 64k | 38.11 | |
Apellis Pharmaceuticals (APLS) | 0.6 | $2.5M | 81k | 30.17 | |
Celldex Therapeutics Com New (CLDX) | 0.5 | $2.2M | 151k | 14.83 | |
Sesen Bio | 0.5 | $2.2M | 1.6M | 1.40 | |
Quidel Corporation | 0.5 | $2.0M | 9.3k | 219.42 | |
Prothena Corp SHS (PRTA) | 0.4 | $2.0M | 197k | 9.99 | |
Otonomy | 0.4 | $1.7M | 413k | 4.05 | |
Kalvista Pharmaceuticals (KALV) | 0.3 | $1.4M | 107k | 12.59 | |
Concert Pharmaceuticals I equity | 0.2 | $1.0M | 104k | 9.82 | |
Liquidia Technologies (LQDA) | 0.2 | $899k | 183k | 4.92 | |
Solid Biosciences | 0.1 | $623k | 307k | 2.03 | |
Protara Therapeutics Com Stk (TARA) | 0.1 | $611k | 36k | 16.83 | |
Amarin Corp Call | 0.1 | $504k | 13k | 39.21 | |
Scpharmaceuticals (SCPH) | 0.1 | $489k | 66k | 7.45 | |
Sarepta Therapeutics (SRPT) | 0.1 | $266k | 1.9k | 140.22 | |
Teligent Com New (TLGTQ) | 0.0 | $220k | 305k | 0.72 | |
Gohealth Com Cl A | 0.0 | $171k | 13k | 13.02 |